Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease-Reference-Cited by-同舟云学术

Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease

Published:2020-07-27 Issue:5 Volume:26 Page:797-799
ISSN:1355-0284
Container-title:Journal of NeuroVirology
language:en
Short-container-title:J. Neurovirol.

Author:

Abrams Rory M.C.^ORCID,Kim Brian D.,Markantone Desiree M.,Reilly Kaitlin,Paniz-Mondolfi Alberto E.,Gitman Melissa R.,Choo S. Yoon,Tse Winona,Robinson-Papp Jessica

Publisher

Springer Science and Business Media LLC

Subject

Virology,Cellular and Molecular Neuroscience,Clinical Neurology,Neurology

Link

https://link.springer.com/content/pdf/10.1007/s13365-020-00884-7.pdf

Reference16 articles.

1. Abrams RMC, Elder GA (2018) Safety of therapeutic plasma exchange for the treatment of Guillain-Barre syndrome in polycythemia vera. Neurologist. 23(6):185–187

2. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH, Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function (2020) COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 75:2950–2973

3. Fehrenbacher JC (2015) Chemotherapy-induced peripheral neuropathy. Prog Mol Biol Transl Sci 131:471–508

4. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC (2014) Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain. 137(Pt 1):33–43

5. Guidon AC, Amato AA (2020) COVID-19 and neuromuscular disorders. Neurology. 94:959–969

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent post–COVID‐19 neuromuscular symptoms;Muscle & Nerve;2023-07-19

2. Bradycardia unresponded to atropin testing was successfully treated with therapeutic plasma exchange in a patient with severe COVID-19 complicated by Guillain-Barré syndrome: A case report;Frontiers in Cardiovascular Medicine;2023-01-19

3. Peripheral nervous system manifestations associated with COVID-19;Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination;2023

4. Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review;Heliyon;2022-11

5. Demographic, Clinical, and Investigational Characteristics of COVID-19- related Guillain-Barré Syndrome with Differences from Typical and Another Virus-related Guillain-Barré Syndrome;Infectious Disorders - Drug Targets;2022-11